T1	Participants 23 77	before total laparoscopic hysterectomy for large uteri
T2	Participants 96 230	To evaluate whether uterine shrinkage induced by gonadotropin-releasing hormone (GnRH) agonists in women with a large uterus (>14 wks)
T3	Participants 405 469	Sixty-two women with symptomatic uterine myomas (size 16-20 wks)
T4	Participants 585 756	women were assigned, at a ratio of 1:1 by random selection, to receive injections of triptorelin depot 11.25 mg 3 months before surgery (group A) or no treatment (group B)
